Healthcare costs are too high. Pharmacy benefit managers can, and do, block access to lower-cost options for Americans, such as biosimilars. Congress must act to ensure Americans have access to these cost-saving options through their PBMs. Read more about the letter NCL sent urging Congress to address the issue now. https://lnkd.in/e-VDRq9X